Material Issues

Among the issues facing our industry, Bristol-Myers Squibb has worked with internal and external stakeholders to identify those sustainability issues that are most material to our company:

Commitment to Corporate Governance, Compliance and Transparency

Focus on Serious Diseases with Significant Unmet Medical Needs

Enabling Research and Development through Protection of Intellectual Property Rights and Pricing

Expanding Access to Medicines and Health Care: Compassion for Patients

Conserving Energy and Water to Protect the Global Environment

These five material issues are highlighted in this website, where we provide detailed information on the systems we have to manage these issues, our efforts to engage with stakeholders, our goals for the future, and the results of our performance.

Last updated October 27, 2006 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

Contractor Information

Student Information

Members of the Community